Article Details

Here's What Recent News From the FDA Means for AstraZeneca | The Motley Fool

Retrieved on: 2021-08-20 12:31:45

Tags for this article:

Click the tags to see associated articles and topics

Here's What Recent News From the FDA Means for AstraZeneca | The Motley Fool. View article details on hiswai:

Excerpt

Key Points. The FDA recently rejected AstraZeneca and FibroGen's roxadustat for the treatment of anemia in patients with chronic kidney disease. Even if ...

Article found on: www.fool.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up